Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 6/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid Ethyl Ester SCHEMBL9173909 | 0.91 | ALDH1A1 (0.35) | ALDH1A1NPC1TSHRHPGDLMNA | |
| Styrene SCHEMBL29228870 | 0.88 | MEN1 (0.39) | ALDH1A1NPC1MAPK1KDM4EMEN1 | |
| Ethyl Acetate SCHEMBL9842714 | 0.87 | ALDH1A1 (0.42) | ALDH1A1NPC1TSHRLMNACA12 | |
| SCHEMBL11674208 | 0.86 | TSHR (0.58) | ALDH1A1NPC1TSHRHPGDLMNA | |
| Ethyl Fumarate SCHEMBL11314607 | 0.86 | HCAR2 (0.53) | ALDH1A1NPC1LMNAMAPT | |
| Urethane SCHEMBL3180161 | 0.85 | ALOX15 (0.44) | ALDH1A1NPC1TSHRHPGDLMNA | |
| SCHEMBL28770620 | 0.85 | TSHR (0.32) | ALDH1A1TSHRHPGDLMNACA12 | |
| SCHEMBL2852122 | 0.84 | TSHR (0.54) | ALDH1A1TSHRHPGDLMNAMAPK1 | |
| SCHEMBL2196152 | 0.84 | TSHR (0.51) | ALDH1A1TSHRHPGDMAPK1CYP3A4 | |
| Acrylic Acid Methyl Ester SCHEMBL1888666 | 0.83 | KMT2A (0.34) | ALDH1A1TSHRHPGDLMNACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384310-A1 | DEGRADABLE DELIVERY PARTICLES BASED FROM AMINE CONTAINING NATURAL MATERIALS | Encapsys, LLC (US) | 2024-06-19 | — | — | EP | claimed |
| EP-4384311-A1 | ARTICLES OF MANUFACTURE WITH DEGRADABLE DELIVERY PARTICLES BASED FROM AMINE CONTAINING NATURAL MATERIALS | Encapsys, LLC (US) | 2024-06-19 | — | — | EP | claimed |
| EP-3596192-B1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES | PROCTER & GAMBLE (US) | 2024-05-15 | — | — | EP | claimed |
| US-20240147990-A1 | Delivery Particles Based On Amine-Thiol-Ene Conjugates and Derivatives | ENCAPSYS, LLC (US) | 2024-05-09 | — | — | US | claimed |
| CN-112638352-B | Composition comprising benefit agent-containing delivery particles | 恩盖普有限公司 | 2024-05-07 | — | — | CN | claimed |
| WO-2024086501-A1 | DELIVERY PARTICLES BASED ON AMINE-THIOL-ENE CONJUGATES AND DERIVATIVES | ENCAPSYS, LLC (US) | 2024-04-25 | — | — | WO | claimed |
| CN-114672375-B | Composition comprising benefit agent-containing delivery particles | 宝洁公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117813153-A | Degradable delivery particles based on amine-containing natural materials | 恩盖普有限公司 | 2024-04-02 | — | — | CN | claimed |
| US-20240002745-A1 | BIODEGRADABLE DELIVERY PARTICLES | ENCAPSYS, LLC (US) | 2024-01-04 | — | — | US | claimed |
| US-20240000073-A1 | BIODEGRADABLE DELIVERY PARTICLES | ENCAPSYS, LLC (US) | 2024-01-04 | — | — | US | claimed |
| WO-2015031418-A1 | MICROCAPSULE-CONTAINING DETERGENT OR CLEANING AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2015-03-05 | — | — | WO | claimed |
| US-8765659-B2 | Cationic polymer stabilized microcapsule composition | THE PROCTER & GAMBLE COMPANY (US) | 2014-07-01 | — | — | US | claimed |
| US-20110245141-A1 | CATIONIC POLYMER STABILIZED MICROCAPSULE COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2011-10-06 | — | — | US | claimed |
| US-7799752-B2 | Compositions comprising encapsulated material | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2010-09-21 | — | — | US | claimed |
| EP-2046935-A2 | CATIONIC POLYMER STABILIZED MICROCAPSULE COMPOSITION | Colgate-Palmolive Company (US) | 2009-04-15 | — | — | EP | claimed |
| WO-2008005693-A2 | CATIONIC POLYMER STABILIZED MICROCAPSULE COMPOSITION | COLGATE-PALMOLIVE COMPANY (US) | 2008-01-10 | — | — | WO | claimed |
| US-20060039934-A1 | Compositions comprising encapsulated material | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2006-02-23 | — | — | US | claimed |
| EP-1534216-A1 | COMPOSITIONS COMPRISING ENCAPSULATED MATERIAL | Quest International Services B.V. (NL) | 2005-06-01 | — | — | EP | claimed |
| EP-1393706-A1 | Fragranced compositions comprising encapsulated material | QUEST INTERNATIONAL B.V. (NL) | 2004-03-03 | — | — | EP | claimed |
| WO-2004016234-A1 | COMPOSITIONS COMPRISING ENCAPSULATED MATERIAL | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2004-02-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240000073-A1 | BIODEGRADABLE DELIVERY PARTICLES | VEGFA, FIBP, HDLBP | ALDH1A1 1616/4885NPC1 176/4885TSHR 2233/4885 |
| US-20240147990-A1 | Delivery Particles Based On Amine-Thiol-Ene Conjugates and Derivatives | ACR, MMAB, UBE3C | ALDH1A1 97/4885NPC1 2275/4885TSHR 2962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.